Login to Your Account

Collaboration is the Key To Efficiency in Drug R&D

By Peter Winter

Monday, August 26, 2013

R&D and "efficiency" aren't terms that seem to naturally blend together when applied to the operations of the biopharmaceutical industry. One only has to point to the many billions of dollars that companies pour into research and development annually. The Washington D.C.-based Pharmaceutical Research and Manufacturers of America (PhRMA), for example, reported in April of this year that its 31 member companies invested an estimated $48.5 billion into R&D in 2012.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription